AstraZeneca Q4 revenue rose 18% to $14.89 billion, surpassing estimates, with oncology sales up 27% to $6.34 billion. FY25 guidance projects high single-digit revenue growth and low double-digit ...

AstraZeneca cooperating with Chinese authorities Update on investigation reassures market Potential fines of 1-5 times unpaid tax Company forecasts robust 2025 growth Shares up 5% at 1105 GMT Feb ...

In recognition of World Cancer Day 2025, AstraZeneca reaffirms its commitment to advancing early detection, innovative treatments, and holistic patient care under this year’s theme, “United by Unique.

The government has defended its negotiations with AstraZeneca, after the pharmaceutical giant ditched a planned £450m investment last week, blaming a shortfall in government funding. Science ...

AstraZeneca’s Imfinzi minimised mortality risk by 27% against a placebo. Credit: © AstraZeneca 2025. The European Medicines Agency’s Committee for Medicinal ...

A variety of stories feature on Saturday's front pages. The Financial Times leads on AstraZeneca's decision to scrap plans for a new vaccine manufacturing plant in Liverpool, calling it "a blow to ...

Copyright 2025 The Associated Press. All Rights Reserved. Share LONDON (AP) — Pharmaceutical company AstraZeneca on Friday cancelled a planned 450 million-pound ...

This is hardly the first time AstraZeneca has bristled at the U.K.’s business environment for the life sciences industry. Back in February 2023, AZ CEO Pascal Soriot attributed the company’s ...

AstraZeneca has dropped its plans to invest £450m in a vaccine manufacturing plant in Speke, Merseyside, blaming a reduction in government support. The move will be seen as a major blow to ...

AstraZeneca has scrapped plans to invest £450m in expanding a vaccine manufacturing plant in Merseyside, blaming a reduction in government support. The pharmaceutical giant announced its decision ...